The briefing
Researchers have advanced pEVAC-PS, an experimental vaccine designed entirely using AI, into a human clinical trial. The effort suggests AI-driven immunogen design could accelerate vaccine development.
Original headline
Researchers Are Using AI to Create Vaccines-and It's Working